Trade CATX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Perspective Therapeutics, Inc. (CATX) is trading at US$3.06, down 2.08% today as of Sep 4, 10:38 EDT. The company has a market capitalisation of US$376.7M. Over the past 52 weeks, CATX has traded between US$1.96 and US$6.16. On Syfe you can trade CATX with $0 commission and add it to your watchlist.
| Previous close | US$3.12 |
|---|---|
| Market cap | US$376.7M |
| 52-week range | US$1.96 – US$6.16 |
| Volume | 929.39K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Year: 2003
Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation
Jul 28, 12:48 PM · MT Newswires
Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role
Jul 8, 11:05 AM · MT Newswires
Perspective Therapeutics, Inc. (CATX) stock is trading at US$3.06, -2.08% from the previous close of US$3.12.
The market cap for Perspective Therapeutics, Inc. (CATX) stock is approximately US$376.7M.
The 52-week high for Perspective Therapeutics, Inc. (CATX) stock is US$6.16.
The 52-week low for Perspective Therapeutics, Inc. (CATX) stock is US$1.96.
Perspective Therapeutics, Inc. (CATX) does not currently pay a dividend.
Stay on top of CATX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
